Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs MERCURY LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA MERCURY LAB. AJANTA PHARMA/
MERCURY LAB.
 
P/E (TTM) x 42.1 21.9 192.4% View Chart
P/BV x 10.3 2.2 481.0% View Chart
Dividend Yield % 1.7 0.4 450.1%  

Financials

 AJANTA PHARMA   MERCURY LAB.
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-24
MERCURY LAB.
Mar-24
AJANTA PHARMA/
MERCURY LAB.
5-Yr Chart
Click to enlarge
High Rs2,3551,303 180.7%   
Low Rs1,208535 225.7%   
Sales per share (Unadj.) Rs334.2629.7 53.1%  
Earnings per share (Unadj.) Rs64.847.1 137.6%  
Cash flow per share (Unadj.) Rs75.670.6 107.1%  
Dividends per share (Unadj.) Rs51.003.50 1,457.1%  
Avg Dividend yield %2.90.4 751.8%  
Book value per share (Unadj.) Rs282.9423.7 66.8%  
Shares outstanding (eoy) m125.921.20 10,493.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.31.5 365.1%   
Avg P/E ratio x27.519.5 140.9%  
P/CF ratio (eoy) x23.613.0 181.0%  
Price / Book Value ratio x6.32.2 290.3%  
Dividend payout %78.77.4 1,059.2%   
Avg Mkt Cap Rs m224,3091,103 20,338.9%   
No. of employees `000NANA-   
Total wages/salary Rs m9,003142 6,348.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m42,087756 5,570.1%  
Other income Rs m84611 7,768.6%   
Total revenues Rs m42,933766 5,601.3%   
Gross profit Rs m11,71990 12,978.3%  
Depreciation Rs m1,35428 4,808.2%   
Interest Rs m724 1,882.5%   
Profit before tax Rs m11,13969 16,097.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,97813 23,519.7%   
Profit after tax Rs m8,16257 14,435.3%  
Gross profit margin %27.812.0 233.0%  
Effective tax rate %26.718.3 146.1%   
Net profit margin %19.47.5 259.1%  
BALANCE SHEET DATA
Current assets Rs m27,221398 6,833.0%   
Current liabilities Rs m8,953129 6,916.3%   
Net working cap to sales %43.435.6 122.0%  
Current ratio x3.03.1 98.8%  
Inventory Days Days321 2,429.6%  
Debtors Days Days111,056 1.0%  
Net fixed assets Rs m17,730281 6,305.2%   
Share capital Rs m25312 2,105.8%   
"Free" reserves Rs m35,364496 7,124.3%   
Net worth Rs m35,617508 7,005.9%   
Long term debt Rs m029 0.0%   
Total assets Rs m45,039680 6,627.5%  
Interest coverage x155.519.1 815.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.91.1 84.0%   
Return on assets %18.38.9 205.8%  
Return on equity %22.911.1 206.0%  
Return on capital %31.513.6 231.5%  
Exports to sales %56.724.8 229.0%   
Imports to sales %9.50-   
Exports (fob) Rs m23,865187 12,754.4%   
Imports (cif) Rs m3,988NA-   
Fx inflow Rs m23,865187 12,754.4%   
Fx outflow Rs m3,9883 128,241.2%   
Net fx Rs m19,876184 10,802.4%   
CASH FLOW
From Operations Rs m7,85182 9,544.9%  
From Investments Rs m654-63 -1,042.6%  
From Financial Activity Rs m-10,511-10 100,869.5%  
Net Cashflow Rs m-2,0069 -22,019.8%  

Share Holding

Indian Promoters % 66.3 73.7 90.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 26.2 0.0 -  
FIIs % 9.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 33.7 26.3 128.1%  
Shareholders   64,315 1,345 4,781.8%  
Pledged promoter(s) holding % 11.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs MERCURY LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs MERCURY LAB. Share Price Performance

Period AJANTA PHARMA MERCURY LAB. S&P BSE HEALTHCARE
1-Day 0.37% -1.65% 0.11%
1-Month -6.04% -6.99% -3.22%
1-Year 49.54% 16.85% 42.65%
3-Year CAGR 28.31% 14.88% 19.86%
5-Year CAGR 34.48% 28.51% 25.90%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the MERCURY LAB. share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.3% stake in the company. In case of MERCURY LAB. the stake stands at 73.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of MERCURY LAB..

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 51.0 per share. This amounted to a Dividend Payout ratio of 78.7%.

MERCURY LAB. paid Rs 3.5, and its dividend payout ratio stood at 7.4%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of MERCURY LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.